145 related articles for article (PubMed ID: 12203805)
1. Nuclear and cytoplasmic p53 expression in pharyngeal squamous cell carcinoma: prognostic implications.
Pukkila MJ; Kumpulainen EJ; Virtaniemi JA; Johansson RT; Halonen PM; Kellokoski JK; Kosunen AS; Nuutinen J; Kosma VM
Head Neck; 2002 Aug; 24(8):784-91. PubMed ID: 12203805
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase expression in pharyngeal squamous cell carcinoma: relation to p53 expression, clinicopathological data, and survival.
Pukkila MJ; Kellokoski JK; Virtaniemi JA; Kumpulainen EJ; Johansson RT; Halonen PM; Kosunen AS; Nuutinen J; Kosma VM
Laryngoscope; 2002 Jun; 112(6):1084-8. PubMed ID: 12160278
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
Allal AS; Waelchli L; Bründler MA
Clin Cancer Res; 2003 Dec; 9(17):6489-96. PubMed ID: 14695153
[TBL] [Abstract][Full Text] [Related]
4. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
[TBL] [Abstract][Full Text] [Related]
5. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
6. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
[TBL] [Abstract][Full Text] [Related]
7. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
[TBL] [Abstract][Full Text] [Related]
8. p53 protein expression in squamous cell carcinoma of the vulva.
Scheistrøen M; Tropé C; Pettersen EO; Nesland JM
Cancer; 1999 Mar; 85(5):1133-8. PubMed ID: 10091798
[TBL] [Abstract][Full Text] [Related]
9. Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study.
Pukkila MJ; Kosunen AS; Virtaniemi JA; Kumpulainen EJ; Johansson RT; Kellokoski JK; Nuutinen J; Kosma VM
J Clin Pathol; 2004 Jul; 57(7):735-9. PubMed ID: 15220367
[TBL] [Abstract][Full Text] [Related]
10. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
[TBL] [Abstract][Full Text] [Related]
11. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
Hsu PK; Li AF; Wang YC; Hsieh CC; Huang MH; Hsu WH; Hsu HS
J Thorac Cardiovasc Surg; 2008 May; 135(5):1029-35. PubMed ID: 18455580
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.
Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS
Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903
[TBL] [Abstract][Full Text] [Related]
13. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
14. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042
[TBL] [Abstract][Full Text] [Related]
15. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
[TBL] [Abstract][Full Text] [Related]
16. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
Miyamoto S; Endoh Y; Hasebe T; Ishii G; Kodama K; Goya M; Ono M; Saitoh N; Chiba T; Ochiai A
Oncol Rep; 2004 Aug; 12(2):245-51. PubMed ID: 15254684
[TBL] [Abstract][Full Text] [Related]
17. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
[TBL] [Abstract][Full Text] [Related]
18. p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change.
McConnell DT; Miller ID; Parkin DE; Murray GI
Gynecol Oncol; 1997 Dec; 67(3):248-54. PubMed ID: 9441771
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract][Full Text] [Related]
20. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
